Structural characterization of exopolysaccharide from Lacticaseibacillus rhamnosus and its protective mechanism against dyslipidemia in obese mice

Puntos clave

• Dyslipidemia is mitigated in obese mice treated with exopolysaccharides.
• Key findings show that exopolysaccharide treatment reduced lipid levels significantly by up to 35%.
• Characterization of the exopolysaccharide is based on biochemical and structural assessments.
• These findings suggest further investigation into dietary probiotics may help manage obesity-related dyslipidemia.